- Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis
This study is looking into a new spray (AP707) for people with long-term pain caused by nerve damage. It compares the spray to a dummy spray to see if it helps reduce pain over time. We want to know if it's safe and effective.
For: Chronic pain due to central Neuropathy of any GenesisAustria · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain
This study is looking at a new cannabis-based medicine called AP707 for people with ongoing back pain. Researchers want to see if it helps reduce pain better than a dummy treatment and how well people tolerate it.
For: Chronic back painGermany · Austria - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to traumatic or post-operative peripheral Neuropathy
This study is looking at a new spray (AP707) for chronic pain caused by nerve damage after an injury or surgery. It aims to see how well it works and if it has side effects, compared to a dummy spray, for adults aged 18 and over.
For: Chronic Pain due to traumatic or post-operative peripheral NeuropathyGermany · Austria - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy
This study is looking for new ways to help people with ongoing pain caused by diabetes affecting their nerves. It's testing a new spray treatment to see if it reduces pain and if it's safe compared to a dummy spray.
For: Chronic pain due to diabetic polyneuropathyAustria · Germany